BREXOGEN
LIVE

Serial Number

79302236

Owner

Brexogen Inc.

Attorney

Kisuk Lee

Filing Date

Oct 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BREXOGEN Trademark

Serial Number: 79302236 • Registration: 6513601

BREXOGEN is a trademark filed by Brexogen Inc. on October 30, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Brexogen Inc. (6 trademarks)

Rooms 901-904, 9, Beobwon-ro 8-gil,

Entity Type: 99

Trademark Details

Filing Date

October 30, 2020

Registration Date

October 12, 2021

Published for Opposition

July 27, 2021

Goods & Services

Medical services relating to the removal and management of stem cells; medical services relating to the treatment of stem cells; medical consulting services in the field of stem cell therapy; Medical human tissue analysis for medical treatment

Testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; scientific research in the fields of biomedicine; [ Research and ] development of cell therapy products; pharmaceutical products development; research relating to pharmaceuticals; scientific [ and technological ] services, namely, research in the field of medicine; scientific and technological services, namely, research in the field of stem cell; scientific and technological services, namely, research in the field of medical products using exosome; [ Scientific and technological services, namely, measuring, analyzing, diagnosing, examining and testing exosomes in body fluids in the field of biotechnology; ] drug discovery services; research and development of technology in the biotechnology fields; biotechnology research; development of new technology for others in the field of biotechnology; scientific and technological services, namely, research in the field of biotechnology services; biotechnology testing * ; Scientific and technological laboratory research, namely, measuring, analyzing, diagnosing, examining and testing exosomes in body fluids in the field of biotechnology *

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Aug 14, 2023 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 16, 2023 INPR
NEW REPRESENTATIVE AT IB RECEIVED
May 13, 2023 NREP
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Dec 20, 2022 NURC
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 17, 2022 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Nov 16, 2022 COC.
ASSIGNED TO PARALEGAL
Nov 16, 2022 PLGL
LIMITATION OF GOODS RECEIVED FROM IB
Sep 18, 2022 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 29, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 29, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 12, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 12, 2021 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 18, 2021 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 21, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 21, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2021 COAR
REFUSAL PROCESSED BY IB
May 3, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 12, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 12, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 9, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 8, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 14, 2021 REPR